AI-Immunology™ platform discovers the key to life-saving cancer vaccines in two days
Evaxion is experiencing great success in developing personalized vaccines for cancer treatment using their AI-Immunology™ platform. It is a method that could be groundbreaking.
ALK continues their growth journey in DTU Science Park in new and larger premises
ALK has become a global and vital player, delivering groundbreaking research, medicine, and solutions to many of the population suffering from allergies.
Celebrating 100 years of innovation: ALK’s pioneering legacy in allergy medicine
Since the 1980s, ALK has been part of DTU Science Park, and today the company is world-leading in allergy immunotherapy treatments and diagnostics.
On 9 June, ALK celebrated its 100th anniversary. While the company has experienced both ups and downs in the last 100 years, ALK has, in recent years, been in a period of growth and expansion whilst still being in line with the company’s backbone of a pioneering spirit.
A chat with two biotech CEOs: The future of the life science industry and the benefits of being part of a community
Just a couple of minutes walk from each other lie the two biotech companies Bioneer and ExpreS2ion Biotechnologies, that are vital cornerstones in the science park’s deep tech community.
GTS institutes in DTU Science Park: FORCE Technology at the forefront of a new green ecosystem
FORCE Technology is a deep tech organization itself, which is why it is obvious for customers, partners and employees to live among so many other deep tech companies.